Dr. Eibl-Lindner is an internationally expert on experimental ophthalmology and serves besides her active clinical work as head of the molecular and cell biology research unit at the University Eye Hospital Munich.

Her clinical expertise comprises ocular traumatology, anterior segment surgery, Ru 106 brachytherapy and stereotactic radiosurgery for uveal melanoma, plastic surgery of the eylid and lacrimal duct and intravitreal/intracameral drug application.

Dr. Eibl-Lindner is the recipient of important awards such as the Research Award for Innovative Basic Science in Ophthalmology and the Glaucoma Research Award of the German Society of Ophthalmology.

She is active member of several editorial boards and regularly publishes in her field.